The natural history of coronary heart disease was studied in 2789 men who had sustained at least one myocardial infarction (MI) at least 3 months previously and who were in New York Heart Association functional class I or II. All were enrolled in the Coronary Drug Project (CDP) between 1966 and 1969 and were allocated to receive placebo medication during a 5-year follow-up period. Forty characteristics determined at entry were selected for univariate and multivariate analysis, with four end points: death from all causes, sudden cardiovascular death, coronary death, and coronary death or definite nonfatal myocardial infarction. The baseline characteristics included demographic, historical, clinical, biochemical and electrocardiographic data.
Baseline cholesterol and smoking at baseline were positively related to the risk of all four end points, whereas serum triglyceride was not related to 5-year prognosis in univariate analyses and was inversely related by multivariate analyses. There was a possible weak association between moderate or vigorous physical activity and decreased mortality during the next 5 years.
The findings suggest a potential benefit of lowering serum cholesterol and cessation of cigarette smoking even after recovery from one or more MIs. The characteristics identified in this study as having the greatest prognostic significance are useful for evaluatiang the predictive value and cost/benefit ratio of other noninvasive and invasive techniques. THE CORONARY DRUG PROJECT (CDP) was a nationwide collaborative study sponsored by the National Heart, Lung, and Blood Institute.' The primary purpose of the CDP was to test the value of several lipid-influencing drugs in the long-term therapy of coronary heart disease (CHD) in men with documented previous myocardial infarction (MI). The results of the studies of these drugs have been published.2-5 One of the major secondary goals of the CDP was to study the long-term prognosis of men after recovery from clinically documented MI. The present report is an overview of the relationship of 40 characteristics determined at baseline and the 5-year incidence of four major end points for the 2789 men in the control (placebo) group. In a previous report, the relationship between these 40 variables and the initial 3-year mortality from all causes in this same group was described.6 lipids," serum uric acid,'2 cigarette smoking'" and plasma glucose;'4 a report on blood pressure is being prepared.
Methods
The background, design, organization, criteria and statistical methods of the CDP have been described in detail. l 1 ' Eight thousand three hundred forty-one men, ages 30-64 years, were recruited by 53 CDP clinical centers between 1966 and 1969. Approximately onethird (2789) of the men were randomly allocated to the placebo group. The study terminated in 1974.
All men were in New York Heart Association'6 functional class I or II and were free from a specified list of diseases and conditions.' All patients were at least 3 months beyond their most recent MI and had no evidence of other major illnesses or recent increases in their cardiac symptoms. Extensive demographic, historical, clinical, biochemical and ECG data were collected on all patients at baseline.1 6 Patients were followed for at least 5 years or until death. They were seen at their clinic for a brief examination every 4 months. A complete history and physical examination, including a resting ECG and chest roentgenogram, were performed annually. Data were submitted on standard forms to the Coordinating Center. Patients were monitored for death and other end points such as recurrent MI, intermediate coronary episodes or acute coronary insufficiency, angina pectoris, ECG changes, stroke, other cardiovascular events, and for the appearance of possible untoward effects such as flushing, nausea, jaundice, insomnia, tremor, venous thromboembolism or deviations of serum enzymes from baseline.
The 40 entry characteristics are listed in table 1. They encompass demographic, clinical, electrocardiographic, biochemical, hematologic and other attributes assessed before randomization.
The characteristics include a set of factors known or suspected to be associated with increased risk of first episodes of MI or CHD. One of the secondary objectives of the CDP was to determine whether these factors were prognostically significant in men recovered from MI. The definition and classification units of the entry characteristics are:
Risk 1 -men who had only one MI and who did not have a defined serious complication (pericarditis, congestive heart failure, shock, arrhythmia or extension of infarction) during the acute episode.
Risk II-men with two or more MIs and men with a single MI who had one or more of the above complications during the acute episode.
Electrocardiographic characteristicsa modified Minnesota code was used to classify the resting ECG.
Frequent ventricular ectopic beatsat least one ectopic beat per 10 recorded beats on the routine 12lead resting ECG.
Cigarette smokingcurrent cigarette smoking in any amount at the time of entry into the CDP, irrespective of previous smoking status.
Relative body weightratio of observed body weight to desirable body weight for height and sex based on the 1959 tables of the Metropolitan Life Insurance Company.'7
Statistical Methods
The statistical methods and techniques involving cross-classification and linear regression have been reported.' 4 6 Four end points were evaluated after 5 years of follow-up: death from all causes, coronary death, sudden cardiovascular death within 1 hour, and coronary death or definite nonfatal MI.
The statistical evaluation of the cross-classification results reported in this paper are presented in terms of Z values. The Z values were calculated in the standard way by dividing the observed difference in percentages of patients with the specified end point for the two groups being compared by the standard error of this difference. The significance levels are conventionally obtained from the Z values by use of a table of the normal (Gaussian) distribution. Traditionally, a Z of absolute value greater than 1.96 or 2.58 is taken as evidence of statistical significance at the 0.05 or 0.01 level, respectively. However, this traditional interpretation of the Z values in long-term studies of this kind must be interpreted cautiously. Because of the large number of variables and analyses, these values cannot be strictly interpreted as indicating significance at these levels. The values are only indicators of the relative size of the statistics.
The relationship of the 40 baseline characteristics to the four end points was assessed by univariate and multivariate techniques. The regression coefficient measures the absolute increase in the estimate end point corresponding to a unit increase in the value of the baseline characteristic. Dividing the regression coefficient by its standard error yields the t value. The t values calculated for the univariate regression are called simple t values. The t values calculated from the regression including all the baseline characteristics are called adjusted t values and are measures of the association of each variable with the end point after adjusting for the effects of all the other variables included in the model. The t values with absolute values greater than 1.96 can be considered a rough guide to statistical significance of the regression coefficients at the 0.05 level, with the same precautions as indicated for Z values.
Results
The mean age of the men in the placebo group was 52.4 ± 7.2 years ( ± SD). The mean time from last infarction until entry into the CDP was 3.0 ± 2.96 years (median 1.98 years). Table 2 presents the 5-year mortality and incidence rates for deaths and nonfatal events for the 2789 men in the placebo group. The majority of deaths were related to CHD, with a high percentage of them (274 of 591, 46.4%) sudden (less than 60 minutes). More than 80% of the men died or had a definite or suspect nonfatal cardiovascular event during the 5-year period. Figure 1 shows the 5-year cumulative event curves for the four major end points and the predicted death rate for an MONTHS OF FOLLOW-UP FIGURE 1. Cumulative event rates per lOOfor thefour major end points for the 2789 men in the placebo group of the Coronary Drug Project (CDP). A curve of expected deaths per 100 from all causesfor an age-and race-matched population ofmen in the United States is also shown. MI = mvocardial infarction. 0no; 1 = suspect or definite 0= no; 1 = suspect or definite 0= no; 1 = suspect or definite 0 = no; 1 = suspect or definite 0= no; 1 = suspect or definite 0=no; 1=yes 0 =no; 1=yes 0=no; 1 =yes 0=no; 1=yes 0=no; 1=yes 0 = no; I = probable or definite 0 = no abnormality; 1 = 1.2.8-1.3.6 (minor)*; 2 1.2.1-1.2.7 (moderate); 3= 1.1.1-1.1.9 (major) 0= no STD; 1 =4.4 (ST junction depr)*; 2 = 4.3 (minor depr); 3 = 4.2 (moderate depr); 4 =4.1 (major depr) 0-no T; 1 = 5.4 (borderline)*; 2 = 5.3 (minor); 3 = 5.2 (moderate); 4 = 5.1 (major) 0 =no STE; 1=9.2 (yes)* 0= no FVEB; 1 = 8.1.2* 0=no VCD, 7.3,7.5*; 1 =7. age-and race-matched group of men from the general U.S. population from 1969 to 1971.18 Table 3 gives the 5-year percentage of patients with definite or suspect nonfatal cardiovascular events since entry. Nearly half (45. 1%) of the men who did not have angina pectoris at entry developed it within 5 years; 21 .4% experienced congestive heart failure, and 16.9% developed new intermittent claudication.
Fatal and Nonfatal Events

CIRCULATION
Baseline Characteristics and Prognosis
Appendix A gives the 5-year event rate for each of the four end points for men with and without each of the 40 characteristics. Many of the 40 baseline characteristics are apparently related to an increased likelihood of the occurrence of at least one of the four end points.
Overview: The 40 Factors Table 4 lists simple t values for all 40 baseline characteristics and the end point death from all causes. It also lists the adjusted t values and the regression coefficients for stepwise multiple linear regression equations with 5, 10, 20 and all 40 baseline variables. The baseline characteristics are listed in the order they were selected by a step up regression analysis. In the univariate regression analyses, 30 of the 40 variables had t values of 2.00 or greater (appendix A). Appendixes B-D list simple and adjusted t values for the 40 baseline characteristics and the end points CHD death, sudden cardiovascular death, and coronary death or definite nonfatal MI.
When the first five selected variables were considered simultaneously, all showed t values of 4.97 or greater, indicating that each was strongly related to mortality even after taking into account the effects of the other four (table 4) . These five baseline variables were ST-segment depression, use of diuretics, New York Heart Association functional classification, ventricular conduction defects and heart rate.
When five additional variables were added to the regression model, adjusted t values for the original five remained high (3.79 or greater, table 4). The five additional variables had adjusted t values of 2.46 or greater. This second set of five variables included cardiomegaly, number of MIs, history of intermittent claudication, serum cholesterol and white blood cell count.
When 10 additional variables were included in the regression model, the original 10 continued to show high adjusted t values. Four of the second 10 had adjusted t values of 2.05 or greater.
Little information was gained when the last 20 variables were added to the model; none of them showed large adjusted t values. The adjusted t values for the original 20 variables were, in general, reduced some-what by adding the last 20 variables because of the interrelations among them.
The coefficients from the 10-variable regression analysis were used to compute a risk score for each man. The men were then ordered by deciles from lowto high-risk score, and the actual observed mortality was determined for each decile (fig. 2) . The observed 5-year death rate for the men in the lowest decile of risk was 7.2%, which was only slightly above the expected 5-year mortality (6.8%) of the males in the U.S. matched for age and race (fig. 1 ). The observed mortality rate increased over the deciles, to 54.8% in the highest decile -7.6 times the rate in the lowest decile.
Of the 591 deaths, 26% occurred in the highest decile and 43% in the upper two deciles of risk score. Table 5 shows the ratio of deaths in deciles 6-10 to deaths in deciles 1-5 by time to death. The risk score is most highly related to death in the first year, with the association steadily decreasing in magnitude each subsequent year, but remaining large even in year 5.
Baseline Cholesterol and Triglycerides
Cholesterol at baseline was related to death (table 6). This was also true for the other three end points (tables 7A and B, Appendixes A-D). On the other hand, triglyceride at entry was not significantly related to 5-year prognosis in univariate analyses. In multivariate analyses that include cholesterol, a significant inverse relationship was shown, i.e., the higher the level of triglycerides, the lower the 5-year event rate (tables 4 and 6, appendixes B-D). Thus, patients with high cholesterol and low triglyceride were at higher risk than those with high cholesterol and high triglyceride. The relationship between cholesterol at baseline and death was present for men younger than 55 years of age at entry and for men 55 years or older ( Because of the widespread interest in the relationship between serum cholesterol level, cigarette smoking and physical activity (all amenable to intervention) to CHD, these characteristics were considered together in regard to their relationship to the four main end points. Table 7A is a list of the 5-year unadjusted total mortality rates for these three baseline characteristics and for eight subsets; table 7B gives these rates adjusted for the other 37 characteristics. In interpreting physical activity, consideration must be given to the possibility that light physical activity at baseline may well reflect previous myocardial damage and that this damage may be the factor that influences prognosis rather than lack of a "protective" influence of increased activity. This inference is supported by comparison of the unadjusted rates and the adjusted rates for moderate or vigorous activity vs light activity: unadjusted 15% vs 24% (table 7A) and adjusted 19% vs 22%c (table  7B) . These data suggest that if there is any protective effect of moderate or vigorous physical activity in men recovered from MI, it is small. 
Cardiovascular Surgery
During the 5-year period of follow-up, only 2.7% of men in the placebo group underwent saphenous vein bypass surgery for coronary artery obstruction. There were 1.4% who underwent arterial surgery other than coronary, and in 0.3%, a pernnanent pacemaker was implanted.
Discussion
In the CDP, 2789 men in functional class I or II after recovery from one or more MIs were assigned to the placebo group. These men were followed for at least 5 years or until death. During this period of follow-up, there was a very high incidence of nonfatal and fatal complications of atherosclerosis and other types of cardiovascular disease, reflecting the extent and severity of their disease. Although coronary angiography was not performed, the criteria for selection and the subsequent morbidity and mortality, as well as the findings of the autopsies performed, all support the conclusion that the vast majority of these 2789 men had severe coronary atherosclerosis. The low incidence (2.7% in 5 years) of men undergoing coronary artery bypass surgery reflects the status of that procedure at the time of the CDP.
The likelihood of death or any of the other three end points within 5 years was very strongly related to the baseline characteristics that reflected the amount of VOL 66, No 2, AUGUST 1982 damage to the heart. Each of the following characteristics may reflect the extent of such myocardial damage: ST-segment depression, resting heart rate over 70 beats/min, ventricular conduction defects, T-wave abnormalities, functional classification, cardiomegaly on chest roentgenogram, use of digitalis or diuretics, history of congestive heart failure, or history of more than one MI. Of the major established risk factors known to be related to initial incidence (first events) of CHD or to death from CHD, both cholesterol and cigarette smoking were significantly related to subsequent morbidity and mortality of the CDP men. These findings indicate a potential benefit of lowering serum cholesterol and cessation of cigarette smoking even after recovery from one or more MI. In addition, there was a possible weak association between moderate or vigorous physical activity and decreased morbidity or mortality during the next 5 years.
Multiple regression analysis made possible the identification of 10 routine variables with independent influence on the risk of developing one or more end points within five years. With their use, we could stratify the group into deciles of increasing risk, with the upper two deciles having a 5-year mortality rate 5.9 times that of the lower two deciles. The lowest-decile group had a 5-year mortality rate only slightly higher than that of the age-and race-matched male population of the U.S.
The characteristics identified in this study as having the greatest prognostic significance are probably applicable and clinically useful in the management of patients. In view of the rapid expansion of the use of complicated and expensive noninvasive and invasive techniques of evaluating patients with CHD, the predictive value and cost/benefit ratio of such procedures should be assessed for their independent value in assessing prognosis over and above the readily and inexpensively determined traits identified in this study. 
